View ValuationMariMed 将来の成長Future 基準チェック /06MariMedは、19.2%と7.8%でそれぞれ年率19.2%で利益と収益が成長すると予測される一方、EPSはgrowで18%年率。主要情報19.2%収益成長率17.95%EPS成長率Pharmaceuticals 収益成長14.4%収益成長率7.8%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日24 Apr 2026今後の成長に関する最新情報お知らせ • Aug 08+ 1 more updateMarimed Inc. Reaffirms Earnings Guidance for the Full Year 2024MariMed Inc. reaffirmed earnings guidance for the full year 2024. MariMed's full year 2024 financial targets are based on organic growth of its existing operating assets and do not include new revenue-generating projects requiring regulatory approvals. As such, the Company's full year 2024 financial targets remain at: Revenue growth of 5% to 7%.お知らせ • May 10MariMed Inc. Provides Earning Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company's financial targets remain at: revenue growth of 5% to 7%.お知らせ • Mar 07MariMed Inc. Provides Earnings Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company expects revenue growth of 5% to 7%.お知らせ • May 09MariMed Inc. Provides Revenue Guidance for the Full Year 2023MariMed Inc. provided revenue guidance for the full year 2023. For the period, the company expects revenue of at least $150 million.お知らせ • May 12MariMed Inc. Provides Earnings Guidance for the Full Year 2022MariMed Inc. provided earnings guidance for the full year 2022. For the period, the company expects revenue to be between $145 million and $150 million.お知らせ • May 21MariMed Inc. Affirms Revenue Guidance for 2021MariMed Inc. continues to track previously announced 2021 revenue guidance of $100 million.すべての更新を表示Recent updatesお知らせ • Apr 25MariMed Inc., Annual General Meeting, Jun 04, 2026MariMed Inc., Annual General Meeting, Jun 04, 2026.お知らせ • Apr 16MariMed Inc. to Report Q1, 2026 Results on May 13, 2026MariMed Inc. announced that they will report Q1, 2026 results After-Market on May 13, 2026新しいナラティブ • Apr 12Branded Cannabis Expansion And Licensing Strategy Will Drive Long Term PotentialCatalysts About MariMed MariMed operates a vertically integrated cannabis business with wholesale, retail and branded products across several U.S. states. What are the underlying business or industry changes driving this perspective?新しいナラティブ • Mar 28Wholesale Saturation And Licensing Delays Will Shape Future Cannabis Brand PerformanceCatalysts About MariMed MariMed is a cannabis company that operates cultivation, manufacturing and retail assets while licensing its brands into additional states. What are the underlying business or industry changes driving this perspective?新しいナラティブ • Mar 13Wholesale Expansion And Licensing-Driven Footprint Will Shape A Stronger Long-Term PositionCatalysts About MariMed MariMed operates a vertically integrated cannabis business with wholesale, retail and branded products across several U.S. states. What are the underlying business or industry changes driving this perspective?お知らせ • Feb 11MariMed Inc. to Report Q4, 2025 Results on Mar 11, 2026MariMed Inc. announced that they will report Q4, 2025 results After-Market on Mar 11, 2026お知らせ • Feb 06MariMed's Eddies Introduces New Limited-Edition Valentine's Seasonal, Berry in Love BettyBetty's Eddies is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine's Day: Berry In Love Betty. Betty's Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. Now available at MariMed's Thrive Dispensary locations and other cannabis retailers throughout Massachusetts, Maryland, Illinois, and Delaware, each libido-enhancing Berry In Love Bettychew is infused with full-spectrum cannabis, CBG, and horny goat weed, an herb used in China that may help increase blood flow and sexual function. All Betty's Eddie chews are vegan, gluten-free, and dairy-free. Berry In Love Betty chews stand out as the brand's first swirled chew, combining an eye-catching presentation with all-natural ingredients made from organic fruits and chocolate. Berry In Love Betty joins a full slate of Betty's Eddies products that feature specific end-effects, including Bedtime Betty's for restful nights, Take It Easy Eddies for stress relief, Go Betty Go for an energy boost, Ache Away Eddies for pain relief, Ache Away Eddies PM for a pain-free night's sleep, Betty's Carameltway for cozy melty moments of mellow, and more.お知らせ • Jan 22MariMed Inc. Launches Hemp-Derived THC Products Under Its Vibations Brand in Rhode IslandMariMed Inc. announced the launch of a hemp-derived THC version of its Vibations™? hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrastructure investment. MariMed believes hemp-derived THC beverages provide a scalable pathway to incremental revenue and accretive gross margin, while maintaining disciplined capital deployment. Distributing a hemp-derived version of Vibations also advances MariMed's Expand the Brand strategy, which is focused on broadening distribution of the Company's core brands and achieving a goal of owning top-selling, national cannabis brands. According to BDSA and Lit Alerts, Vibations is a top 10 selling cannabis beverage brand in Illinois, Massachusetts, Maryland, and Delaware. The hemp-derived THC version of Vibations is infused with 5mg of THC per stick. Flavors available for the Rhode Island launch include Lemon Lime (Sugar Free), Half & Half, Strawberry Lemonade, and Tropical Punch. Distribution will be provided through licensed Rhode Island liquor stores that are authorized to carry hemp THC beverages and products, providing an efficient and scalable retail channel for market entry. There are currently more than 150 licensed and approved liquor stores in the state. Distribution of Vibations in Rhode Island is supported by Craft Collective Homegrown, the leading hemp beverage distributor in the state, which will manage weekly ordering and delivery. MariMed has also entered a new partnership with Modern Infusions, the hemp THC beverage division of Theory Wellness, to manage sales execution and local marketing initiatives, including distributor management, account development, retail merchandising, and short and long-term sales planning. The Company is also developing plans to expand distribution of Vibations into additional markets during the first half of 2026. Those plans will be contingent on the early performance of the Rhode Island launch and other regulatory considerations and would be implemented using a similarly disciplined and capital-efficient distribution model.お知らせ • Oct 29Marimed Announces Strategic Exit from Missouri MarketMariMed Inc. announced that it has completed a strategic review of its Missouri business operations and decided to exit the market, effectively immediately. Since 2024, the Company has managed the Missouri operations of another licensed cannabis operator and distributed certain of its brands there under a Managed Services and Licensing Agreement, while awaiting license transfer approval from the state. The Company will no longer manage the facility and will no longer seek the license transfer. MariMed continues to own or manage revenue-generating operations in six states, including 13 dispensaries and six cultivation and processing facilities in Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania. Exiting Missouri is expected to improve the Company’s overall financial performance, particularly gross margin and adjusted EBITDA, and allow management to focus resources on higher return opportunities.お知らせ • Sep 29MariMed Inc. to Report Q3, 2025 Results on Nov 05, 2025MariMed Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025お知らせ • Jul 08MariMed Inc. to Report Q2, 2025 Results on Aug 06, 2025MariMed Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025お知らせ • May 29MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDoseMariMed Inc. continued to drive innovation with the launch of MycroDose by Nature's Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of functional mushrooms in a convenient pill form. MycroDose by Natures Heritage delivers four targeted, plant-based solutions designed to enhance mental clarity, promote relaxation, improve focus, and support overall well-being in four distinct formulations. They are available now in Massachusetts at MariMed's own Panacea Wellness stores and other select dispensaries. The new line was developed to provide new and existing consumers with a unique, balanced, and controlled experience. Each of the four MycroDose by Nature' Heritage products are uniquely crafted with a specific blend of all natural vegan ingredients to cater to a variety of needs. The complete line-up includes: Chill - Designed for relaxation and stress relief, Chill features THC, CBD, and q, blended with the functional mushrooms Organic Cordyceps and Organic Lion's Mane, and the root plant, Ashwagandha. G'Night - A formulation aimed at improved sleep and deep relaxation, G'Night combines THC, CBN, CBD with functional mushrooms Organic Reishi and Organic Lion's Mane, as well as Chamomile and Magnesium. Remedy - A product focused on reducing inflammation while providing a calm state of mind, Remedy features THC, CBD, and CBC, blended with the functional mushroom Oyster, Ginger root, Turmeric, and Piperine. Spark - An energizing blend designed to improve energy, focus, and mental clarity, Spark is formulated with Shoitake mushrooms, Organic Lion's Mane, Ginseng, THCV, and THC.お知らせ • May 01MariMed Inc., Annual General Meeting, Jun 12, 2025MariMed Inc., Annual General Meeting, Jun 12, 2025. Location: sheraton norwood, 1125 boston providence turnpike, norwood, massachusetts 02062, United Statesお知らせ • Apr 08MariMed Inc. to Report Q1, 2025 Results on May 07, 2025MariMed Inc. announced that they will report Q1, 2025 results After-Market on May 07, 2025お知らせ • Apr 07MariMed Inc. Promotes Ryan Crandall to Chief Commercial OfficerMariMed Inc. has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine. Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty’s Eddies. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2.お知らせ • Apr 03MariMed Inc.'s Betty's Eddies Expands Top-Selling Brand with Introduction of THC & CBG-Infused Caramel ChewsBetty's Eddies is expanding its lineup with the introduction of delicious caramel chews: Betty's Caramelt Away. Betty's Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. Deuting in time for National Caramel Day on April 5, Betty's Caramelt Away chews are now available at select cannabis retailers throughout Massachusetts, with plans for expansion into MariMed's wholesale markets in the future. Each chew wraps customers in warmth with the rich, comforting flavor of classic caramel. They're infused with a soothing blend of full-spectrum hash and CBG that lets consumers sink into sweet, cozy melty moments of mellow. Betty's Caramelt Away joins a full slate of Betty's Eddies products that feature specific end-effects, including Bedtime Betty's for restful nights, Take It Easy Eddies for stress relief, Go Betty Go for an energy boost, Ache Away Eddies for pain relief, Smashin' Passion for sexual wellness, and Betty Good Times for any time.お知らせ • Apr 02Marimed Launches Nature's Heritage Flower in IllinoisMariMed Inc. has officially introduced its Nature's Heritage™?-branded cannabis flower, pre-rolls, and vapes in Illinois. This marks the first time the brand's premium products are available in the state. The launch follows the late 2024 openning of MariMed's Mt. Vernon, Illinois, cultivation facility. Nature's Heritage products are available at MariMed's five -branded dispensaries and other select retailers in the state. Thrive-branded dispensaries and other select retailer in the state. The entire portfolio of MariMed's award-winning brands is now available in the state. The Company's processing facility commenced distribution of its other products, including Betty's Eddies™?, Bubby's Baked™?, InHouse™?, and Vibations™? products, in late 2023. Since then, MariMed has successfully penetrated the market, with its products currently available in approximately 82% of Illinois dispensaries.お知らせ • Mar 05MariMed Inc. (OTCPK:MRMD) completed the acquisition of First State Compassion Center Inc.MariMed Inc. (OTCPK:MRMD) entered into an agreement to acquire First State Compassion Center Inc. on July 1, 2023. MariMed Inc. (OTCPK:MRMD) completed the acquisition of First State Compassion Center Inc. on March 3, 2025.お知らせ • Feb 11MariMed Inc. to Report Q4, 2024 Results on Mar 05, 2025MariMed Inc. announced that they will report Q4, 2024 results After-Market on Mar 05, 2025お知らせ • Oct 07MariMed Inc. to Report Q3, 2024 Results on Nov 06, 2024MariMed Inc. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024お知らせ • Aug 08+ 1 more updateMarimed Inc. Reaffirms Earnings Guidance for the Full Year 2024MariMed Inc. reaffirmed earnings guidance for the full year 2024. MariMed's full year 2024 financial targets are based on organic growth of its existing operating assets and do not include new revenue-generating projects requiring regulatory approvals. As such, the Company's full year 2024 financial targets remain at: Revenue growth of 5% to 7%.お知らせ • Jul 10MariMed Inc. to Report Q2, 2024 Results on Aug 07, 2024MariMed Inc. announced that they will report Q2, 2024 results on Aug 07, 2024お知らせ • Jul 02MariMed Inc. Announces Approval of Adult-Use Sales at Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and MarylandMariMed Inc. announced that it received approval of the Massachusetts Cannabis Control Commission ("MCCC") to commence adult-use retail sales at its QuincyPanacea Wellness dispensary. Panacea WellnessQuincy is the third MariMed dispensary in Massachusetts that offers adult-use sales, which is the maximum permissible by state law. The other two adult-use dispensaries are in Leverly and Middleboro. The Company commenced adult-use sales in Quincy on July 2, 2024. The dispensary, which has been operating as a medical-only location, offers a curated selection of products from across the Company's award-winning brand portfolio. They include Nature's Heritage flower and concentrates, Betty's Eddies fruit chews, Bubby's Baked soft-baked goods, Vibations hydrating cannabis drink mixes, and the full suite of InHouse branded products. In addition to the three Panacea Wellness locations, MariMed's branded cannabis products are distributed to over 200 dispensaries in the Massachusetts cannabis market, which, according to the MCCC, generated $1.8 billion in total cannabis sales during 2023. The Company also announced regulatory approval updates that may have a positive impact on future operational and financial results. These include: Ohio: Receipt of a provisional dual-use license to add recreational sales to medical dispensary in Tiffin. Upon state final inspection, MariMed expects to commence adult-use sales. Maryland: Receipt of a Certificate of Occupancy and state approval to commence operations in the newly expanded area of cultivation facility in Hagerstown, Maryland. MariMed will begin growing in the new flower rooms immediately to meet the high demand for its Nature's Heritage flower and other branded products in that state. Also in Maryland, the pre-occupancy inspection of second Thrive dispensary in the state is expected to occur. The Company hopes to commence adult-use operations in this dispensary, located in Upper Marlboro, a town in Prince George's County, later this month.お知らせ • May 10MariMed Inc. Provides Earning Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company's financial targets remain at: revenue growth of 5% to 7%.お知らせ • Apr 10MariMed Inc. (OTCPK:MRMD) completed the acquisition of Operating assets of Our Community Wellness & Compassionate Care Center, Inc for $5.3 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million on February 1, 2024. The purchase consideration is comprised of $2 million of cash in the aggregate, a $2 million note to be issued to the sellers at the time of closing, and shares of MariMed's common stock with a fair value of $1.25 million based on a formulaic calculation, to be issued at the time of closing. Transaction is subject to approval by the Maryland Cannabis Administration. MariMed expects this acquisition to be completed in 2024. MariMed Inc. (OTCPK:MRMD) completed the acquisition of Operating assets of Our Community Wellness & Compassionate Care Center, Inc on April 9, 2024.お知らせ • Apr 09MariMed Inc. to Report Q1, 2024 Results on May 08, 2024MariMed Inc. announced that they will report Q1, 2024 results After-Market on May 08, 2024お知らせ • Mar 20MariMed Inc., Annual General Meeting, Jun 06, 2024MariMed Inc., Annual General Meeting, Jun 06, 2024.お知らせ • Mar 08MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million on February 1, 2024. The purchase consideration is comprised of $2 million of cash in the aggregate, a $2 million note to be issued to the sellers at the time of closing, and shares of MariMed's common stock with a fair value of $1.25 million based on a formulaic calculation, to be issued at the time of closing. Transaction is subject to approval by the Maryland Cannabis Administration. MariMed expects this acquisition to be completed in 2024.お知らせ • Mar 07MariMed Inc. Provides Earnings Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company expects revenue growth of 5% to 7%.お知らせ • Feb 06MariMed Inc. to Report Q4, 2023 Results on Mar 06, 2024MariMed Inc. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Mar 06, 2024お知らせ • Dec 04MariMed Inc. Commences Operations of Processing Facility in Mt. Vernon, IllinoisMariMed Inc. announced it has begun manufacturing and processing cannabis products in its new processing kitchen in Mt. Vernon, Illinois. After lengthy construction and regulatory delays, the Company expects that its award-winning products will be available at dispensaries in Illinois in time for the holidays. These include MariMed's five Thrive Dispensary-branded retail locations in the state. The processing facility contains an extraction lab to produce concentrates, and a production kitchen for the manufacture of edibles and other derivative products. The cultivation facility is currently under construction in the same facility and is expected to be completed in 2024. MariMed intends to manufacture and distribute its proprietary brands and products throughout Illinois. That includes its Betty's Eddies fruit chews, which was the top-selling edible in Illinois until 2020 through a third-party licensing agreement, Bubby's Baked soft and chewy baked edibles, Vibations hydrating drink mix, InHouse gummies, K Fusion chewable tablets, and more. Upon completion of the cultivation facility construction the Company plans to commence selling its Nature's Heritage flower through retail and wholesale channels. MariMed operates five Thrive Dispensary locations in Anna, Casey, Harrisburg, Metropolis, and Mt. Vernon, Illinois.お知らせ • Nov 05MariMed Inc. Announces Executive ChangesMariMed Inc. announced that effective October 31, 2023, Susan M. Villare resigned as Chief Financial Officer of the Company. The Board of Directors has appointed Jon Levine, President and CEO, as the Company’s Interim Chief Financial Officer and has initiated a search process to identify and engage a new Chief Financial Officer.お知らせ • Nov 04MariMed Inc. to Report Q3, 2023 Results on Nov 08, 2023MariMed Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023お知らせ • Sep 14MariMed Inc. Announces its Bubby's Baked Introduces New THC-Infused Blueberry Muffin Bites to Start Day on High NoteMariMed Inc. headed to the blueberry bush to create the latest addition to its Bubby’s Baked™ THC-infused soft baked goods line of edibles. The Company’s new Blueberry Muffin bites are soft and baked in small batches, a made-from-scratch ode to breakfast. They join the popular Bubby’s Baked line inspired by the original pot brownie recipe and are available at select dispensaries in Massachusetts, Maryland, and Delaware. Each Bubby’s Baked Blueberry Muffin bite is an enticing combination of sweetness and tartness, bursting with real blueberries and infused with full-spectrum cannabis. With 35% of cannabis consumers saying they have recently enjoyed a cannabis baked good, Bubby’s Baked Blueberry Muffin bites are sure to satisfy the most discerning sweet tooth. In Massachusetts, they are precision-dosed with 5 mg of cannabis; in Maryland and Delaware, they are available with 10 mg of cannabis. The new Blueberry Muffin bites join the other three flavors in the Bubby’s Baked line-up, including classic Brownie, Choco Chip and Snickerdoodle. The Bubby’s Baked brand was inspired by the original homemade pot brownie. The brand’s classic Brownie flavor was intended to recreate and elevate the nostalgic experience so many consumers remember as their first cannabis-infused edible. Other flavors in the line include Choco Chip and Snickerdoodle.お知らせ • Jun 30MariMed Inc. to Report Q2, 2023 Results on Aug 02, 2023MariMed Inc. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023お知らせ • May 09MariMed Inc. Provides Revenue Guidance for the Full Year 2023MariMed Inc. provided revenue guidance for the full year 2023. For the period, the company expects revenue of at least $150 million.お知らせ • Feb 02MariMed Inc. to Report Q4, 2022 Results on Mar 01, 2023MariMed Inc. announced that they will report Q4, 2022 results After-Market on Mar 01, 2023お知らせ • Jul 12MariMed Inc. to Report Q2, 2022 Results on Aug 08, 2022MariMed Inc. announced that they will report Q2, 2022 results After-Market on Aug 08, 2022お知らせ • May 13+ 1 more updateMariMed Inc. Announces Appointment of Jon Levine as Chief Administration OfficerMariMed Inc. announced the appointment of Jon Levine to the new role of Chief Administration Officer effective May 12, 2022. Mr. Levine co-founded MariMed with Chief Executive Officer Bob Fireman. As the Company's CFO, he drove the financial discipline required to make MariMed an industry leader. The Company's finance and accounting teams, operations, sales nd marketing, and external communications will all now report to Mr. Levine as CAO.お知らせ • May 12MariMed Inc. Provides Earnings Guidance for the Full Year 2022MariMed Inc. provided earnings guidance for the full year 2022. For the period, the company expects revenue to be between $145 million and $150 million.お知らせ • May 06MariMed Inc. (OTCPK:MRMD) acquired Green Growth Group, Inc. for $3.4 million.MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc. for $3.4 million on January 18, 2022. The transaction is subject to customary closing conditions and regulatory approvals. The acquisition is conditioned upon the approval by the IDA, among other closing conditions, which is expected to occur by July 2022. The purchase price of $3.4 million shall be comprised of $1.9 million in cash and shares of the Company's common stock valued at $1.5 million. The close of this transaction enables MariMed to add cultivation, manufacturing, and distribution to its existing retail cannabis operations in Illinois. MariMed will bring its full product portfolio of award-winning and top-selling brands, genetics, and products to one of the top cannabis markets in the United States. The Company has commenced development of a state-of-the-art cultivation and processing facility in Mt. Vernon, IL and anticipates commencing operations in the fourth quarter of 2022. MariMed Inc. (OTCPK:MRMD) completed the acquisition of Green Growth Group, Inc. on May 5, 2022.お知らせ • Apr 13MariMed Inc. to Report Q1, 2022 Results on May 10, 2022MariMed Inc. announced that they will report Q1, 2022 results After-Market on May 10, 2022お知らせ • Mar 10MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Provisional Dispensary License from Green House Naturals, LLC.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Provisional Dispensary License from Green House Naturals, LLC on March 8, 2022. The assets of Green House Naturals to be acquired by MariMed include a provisional adult use dispensary license subject to approval of the Massachusetts Cannabis Control Commission, a Host Community Agreement to operate a dispensary from the City of Beverly and the assignment of the leasehold approved for the business. MariMed anticipates the Beverly adult use dispensary will be operational during the second half of 2022.お知らせ • Feb 16MariMed Inc. to Report Q4, 2021 Results on Mar 16, 2022MariMed Inc. announced that they will report Q4, 2021 results After-Market on Mar 16, 2022お知らせ • Feb 08Marimed Inc. Top-Selling Brands and Products Now Available in DelawareMariMed Inc. announced that its award-winning cannabis brands and products are now available in Delaware. As a result of new regulations in the Delaware Medical Marijuana program, MariMed has expanded its licensing agreement with First State Compassion Center (“FSC”), a leading Delaware vertically integrated cannabis operator, to produce and distribute its branded cannabis edibles. First State Compassion will have exclusive rights to produce and distribute MariMed’s Betty’s Eddies® infused fruit chews, Bubby’s Baked™ soft and chewy, full-spectrum cannabis baked bites, and k FUSION chewable micro-dose mints. MariMed and FSC have a longstanding advisory relationship. FSC currently licenses MariMed’s Nature’s Heritage® premium flower and concentrates brand. With the addition of Delaware, MariMed’s brands will now be available in six states plus Puerto Rico with more to come in the future.お知らせ • Jan 19MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc.MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc. on January 18, 2022. The transaction is subject to customary closing conditions and regulatory approvals.お知らせ • Jan 06MariMed Inc. (OTCPK:MRMD) entered into a definitive membership interest purchase agreement to acquire Kind Therapeutics USA, LLC from Jennifer DiPietro, Susan Zimmerman and Sophia Leonard-Burns for $20 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive membership interest purchase agreement to acquire Kind Therapeutics USA, LLC from Jennifer DiPietro, Susan Zimmerman and Sophia Leonard-Burns for $20 million on December 31, 2021. As reported, the aggregate purchase price to be paid by MariMed Inc. for Kind Therapeutics USA shall be $20 million, of which $13.5 million shall be payable in cash (subject to adjustment) and $6.5 million shall be payable by the issuance of four-year 6% promissory notes of the MariMed to the members of Kind Therapeutics. Upon execution, MariMed deposited, in escrow, the sum of $5 million as a contract down-payment. In related transactions, MariMed Advisors Inc., a wholly-owned subsidiary of MariMed Inc. entered into membership interest purchase agreements to acquire Jennifer DiPietro’s entire equity ownership interest of 99.7% in Mari Holdings MD LLC and 94.3% Mia Development LLC on December 31, 2021. The closing of the agreements is subject to the fulfilment of closing conditions including but not limited to approval by the Maryland Medical Cannabis Commission.お知らせ • Dec 08MariMed Inc. Unveils World’s Large Cannabis-Infused Brownie to Celebrate Launch of Its “Bubby’s Baked” BrandMariMed Inc. unveiled the world’s large cannabis-infused brownie in celebration of the launch of its new brand Bubby’s Baked and National Brownie Day on December 8. Inspired by the original cannabis-infused, homemade brownie, every delicious, soft, and chewy Bubby’s bite is made from scratch in small batches, and infused with precision-dosed, full spectrum cannabis. They’re perfect for sharing high times with friends this holiday season. Bubby’s comes in three classic confectionery recipes – brownie, chocolate chip, and snickerdoodle. The line is available throughout Massachusetts, including MariMed’s Panacea dispensary in Middleborough, Massachusetts. It is expected to hit dispensary shelves in Delaware and Maryland early next year. Bubby’s are made with all natural ingredients, starting with the basics: flour, butter, eggs, and sugar. There are no artificial flavors or preservatives in any flavor. Each Bubby’s single-serving bite contains 5mg of THC in Massachusetts in compliance with state regulations. To commemorate the launch of Bubby’s, MariMed’s craft confectioners in Massachusetts baked a larger-than-life version of a Bubby’s soft-baked brownie that is believed to be the world’s large THC-infused brownie ever made. The confection measures 3 feet wide by 3 feet long and 15 inches tall, weighs a whopping 850 pounds, and contains 20,000mg of THC.お知らせ • Sep 10Marimed, Inc.'s Betty's Eddies® Brand Launches Singles and Brings Back Multi-PacksMariMed Inc. announced the launch of new SKUs of its Betty’s Eddies brand of cannabis infused fruit chews. Answering the call of the brand’s customers, this month the company is rolling out single-serving options and bringing back multi-packs that will feature a variety of flavors. Offering the Betty’s Eddies brand in a single-serve package will provide a low-cost, convenient option to drive trial of the brand among new customers, as well as for impulse purchases at point-of-sale. All of Betty’s Eddies fruit chews will be offered in the single-serve format, including the sleep-enhancing Betty’s Bedtime, immunity-boosting Elderbetty, libido-inducing Smashin’ Passion. Betty’s Eddies customers were also demanding the relaunch of multi-packs, which will contain an assortment of the brand’s original five classic flavors, including Berry Good Things, Orange You Beautiful, O’ My Grapeness, Little Lemon Heaven, and Lime a Good Person. The multi-pack will also afford new users the opportunity to try multiple flavors in order to pick their favorite on their next purchase. Handcrafted with full-spectrum cannabis oil, organic fruits and vegetables, Betty’s Eddies chews are vegan, gluten-free and dairy-free. The brand has been the top-selling cannabis edible in Maryland and Massachusetts, according to LeafLink, and is also available in Maine, Nevada, Rhode Island, and Puerto Rico.お知らせ • May 21MariMed Inc. Affirms Revenue Guidance for 2021MariMed Inc. continues to track previously announced 2021 revenue guidance of $100 million.お知らせ • Mar 25MariMed Inc. Provides Earnings Guidance for the Full Year 2021Marimed Inc. Provides Earnings Guidance for the Full Year 2021. The company is initiating full year 2021 revenue guidance of $100 million.お知らせ • Mar 19MariMed Inc. to Report Q4, 2020 Results on Mar 24, 2021MariMed Inc. announced that they will report Q4, 2020 results on Mar 24, 2021お知らせ • Jan 29MariMed Inc. Launches Cannabis-Infused Betty’s Eddies™ “Smashin’ Passion” Aphrodisiac ChewsMariMed Inc. announced that it is heating up the cannabis edibles market in time for Valentine’s Day with the release of its Betty’s Eddies™ Smashin’ Passion chews. Scientifically formulated to stimulate mind and body, Smashin’ Passion chews will be available starting in February at the Company’s spacious Panacea Wellness dispensary in Middleboro, MA, and later at select dispensaries in Massachusetts, Nevada, Rhode Island, and Puerto Rico. The tenth addition to the award-winning Betty’s Eddies line of all-natural fruit chews, Smashin’ Passion chews are made with pure freeze-dried passionfruit and a proprietary blend of four all-natural aphrodisiacs: damiana, horny goat weed, maca root, and muira puama.お知らせ • Dec 04MariMed Inc. Announces Launch of Nature’s Heritage™ Solventless Concentrates in MassachusettsMariMed Inc. announced the launch of two solventless concentrate products from its wholly owned Nature’s Heritage cannabis brand. One-gram jars of kief and bubble hash extracted from a variety of Nature’s Heritage strains are now available for purchase at dispensaries across Massachusetts, including the Company’s Panacea Wellness dispensary in Middleboro, MA. Kief is the trichome pollen sifted from dry cannabis flower without the use of chemical solvents. It contains the highest concentration of cannabinoids and terpenes on a cannabis plant, and is often referred to as “cannabis crystals” in reference to its appearance and impressive effects. Similarly, bubble hash is an all-natural solventless cannabis extract created through an ice water extraction process. Nature’s Heritage is one of the top-selling cannabis flower brands in Massachusetts and Maryland. With the addition of the kief and bubble hash, the Company continues to grow and expand its portfolio of product offerings under the Nature’s Heritage brand.お知らせ • Nov 18Marimed Inc. Introduces Nature’S Heritage™ Rso CapsulesMariMed Inc. announced the product release of “RSO” capsules from the company’s proprietary cannabis flower and concentrate brand, Nature’s Heritage. The capsules are made with powderized RSO and are available in 5 mg, 25 mg, and 100 mg doses at the company’s panacea wellness dispensary and other dispensaries in Massachusetts. RSO is a high-THC cannabis oil reported to have positive results for patients managing a variety of medical conditions and their side effects. The RSO name is homage to the Canadian cannabis activist, Rick Simpson, who created the oil to treat his skin cancer after reading a 1975 journal of the National Cancer Institute study about the efficacy of high doses of THC in cancer treatment. RSO has a thick consistency and is traditionally incorporated into foods or beverages for ingestion or used as a topical directly on affected areas.お知らせ • Nov 05MariMed Inc. to Report Q3, 2020 Results on Nov 09, 2020MariMed Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 09, 2020お知らせ • Oct 30MariMed Launches ElderBetty ChewsMariMed Inc. announced the release of the new Betty’s Eddies™ ElderBetty chews. This is the first THC-infused cannabis edible on the market in multiple states to include elderberry, vitamin D, and zinc. Betty’s Eddies chews are available for sale in various dosages at more than 150 licensed medical and adult-use cannabis dispensaries in Massachusetts, Maryland, Nevada, Rhode Island, and Puerto Rico.お知らせ • Oct 06MariMed Launches Natures’ Heritage Solventless “Live Rosin” in MassachusettsMariMed Inc. launched a new line of solventless concentrates under its Nature’s Heritage brand. Live rosin is a highly concentrated solvent-free cannabis hash oil where terpenes and cannabinoids are largely preserved from the natural plant. These Nature’s Heritage concentrates will be available in rotating varieties of sativa, indica, and hybrid strains. Nature’s Heritage has already established itself as one of the top-selling and most sought-after flower brands in Massachusetts and Maryland. The Company is now building on this success with the launch of live rosin and additional products, including other concentrates, a variety of RSO products, vaporizers, and pre-rolls, coming to market over the next several months, all within the Nature’s Heritage brand.業績と収益の成長予測OTCPK:MRMD - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028210-812112/31/2027172-10-4-4212/31/2026162-17-5-5212/31/2025160-1478N/A9/30/2025157-1824N/A6/30/2025157-16-22N/A3/31/2025158-16-45N/A12/31/2024158-12-57N/A9/30/2024158-14-610N/A6/30/2024156-17-218N/A3/31/2024152-17-516N/A12/31/2023149-16-128N/A9/30/2023146-1-106N/A6/30/20231416-112N/A3/31/20231379-17-6N/A12/31/202213413-57N/A9/30/20221292013N/A6/30/20221292320N/A3/31/202212871838N/A12/31/202112171836N/A9/30/2021111181530N/A6/30/202191171020N/A3/31/2021689511N/A12/31/2020512-13N/A9/30/202036-80-52N/A6/30/202033-89-10-2N/A3/31/202050-84-28-18N/A12/31/201946-81-34-24N/A9/30/201944-10N/A-26N/A6/30/201936-7N/A-25N/A3/31/201913-12N/A-8N/A12/31/201812-14N/A-3N/A9/30/201810-7N/A-2N/A6/30/20188-4N/A2N/A3/31/20187-3N/A1N/A12/31/20176-1N/A2N/A9/30/201760N/A3N/A6/30/201750N/A0N/A3/31/201740N/A0N/A12/31/201640N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MRMD今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: MRMD今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: MRMD今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: MRMDの収益 ( 7.8% ) US市場 ( 11.6% ) よりも低い成長が予測されています。高い収益成長: MRMDの収益 ( 7.8% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MRMDの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/13 01:36終値2026/05/13 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MariMed Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Joseph GomesNOBLE Capital Markets, Inc.Andrew SempleVentum Financial CorpPablo ZuanicZuanic & Associates
お知らせ • Aug 08+ 1 more updateMarimed Inc. Reaffirms Earnings Guidance for the Full Year 2024MariMed Inc. reaffirmed earnings guidance for the full year 2024. MariMed's full year 2024 financial targets are based on organic growth of its existing operating assets and do not include new revenue-generating projects requiring regulatory approvals. As such, the Company's full year 2024 financial targets remain at: Revenue growth of 5% to 7%.
お知らせ • May 10MariMed Inc. Provides Earning Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company's financial targets remain at: revenue growth of 5% to 7%.
お知らせ • Mar 07MariMed Inc. Provides Earnings Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company expects revenue growth of 5% to 7%.
お知らせ • May 09MariMed Inc. Provides Revenue Guidance for the Full Year 2023MariMed Inc. provided revenue guidance for the full year 2023. For the period, the company expects revenue of at least $150 million.
お知らせ • May 12MariMed Inc. Provides Earnings Guidance for the Full Year 2022MariMed Inc. provided earnings guidance for the full year 2022. For the period, the company expects revenue to be between $145 million and $150 million.
お知らせ • May 21MariMed Inc. Affirms Revenue Guidance for 2021MariMed Inc. continues to track previously announced 2021 revenue guidance of $100 million.
お知らせ • Apr 25MariMed Inc., Annual General Meeting, Jun 04, 2026MariMed Inc., Annual General Meeting, Jun 04, 2026.
お知らせ • Apr 16MariMed Inc. to Report Q1, 2026 Results on May 13, 2026MariMed Inc. announced that they will report Q1, 2026 results After-Market on May 13, 2026
新しいナラティブ • Apr 12Branded Cannabis Expansion And Licensing Strategy Will Drive Long Term PotentialCatalysts About MariMed MariMed operates a vertically integrated cannabis business with wholesale, retail and branded products across several U.S. states. What are the underlying business or industry changes driving this perspective?
新しいナラティブ • Mar 28Wholesale Saturation And Licensing Delays Will Shape Future Cannabis Brand PerformanceCatalysts About MariMed MariMed is a cannabis company that operates cultivation, manufacturing and retail assets while licensing its brands into additional states. What are the underlying business or industry changes driving this perspective?
新しいナラティブ • Mar 13Wholesale Expansion And Licensing-Driven Footprint Will Shape A Stronger Long-Term PositionCatalysts About MariMed MariMed operates a vertically integrated cannabis business with wholesale, retail and branded products across several U.S. states. What are the underlying business or industry changes driving this perspective?
お知らせ • Feb 11MariMed Inc. to Report Q4, 2025 Results on Mar 11, 2026MariMed Inc. announced that they will report Q4, 2025 results After-Market on Mar 11, 2026
お知らせ • Feb 06MariMed's Eddies Introduces New Limited-Edition Valentine's Seasonal, Berry in Love BettyBetty's Eddies is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine's Day: Berry In Love Betty. Betty's Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. Now available at MariMed's Thrive Dispensary locations and other cannabis retailers throughout Massachusetts, Maryland, Illinois, and Delaware, each libido-enhancing Berry In Love Bettychew is infused with full-spectrum cannabis, CBG, and horny goat weed, an herb used in China that may help increase blood flow and sexual function. All Betty's Eddie chews are vegan, gluten-free, and dairy-free. Berry In Love Betty chews stand out as the brand's first swirled chew, combining an eye-catching presentation with all-natural ingredients made from organic fruits and chocolate. Berry In Love Betty joins a full slate of Betty's Eddies products that feature specific end-effects, including Bedtime Betty's for restful nights, Take It Easy Eddies for stress relief, Go Betty Go for an energy boost, Ache Away Eddies for pain relief, Ache Away Eddies PM for a pain-free night's sleep, Betty's Carameltway for cozy melty moments of mellow, and more.
お知らせ • Jan 22MariMed Inc. Launches Hemp-Derived THC Products Under Its Vibations Brand in Rhode IslandMariMed Inc. announced the launch of a hemp-derived THC version of its Vibations™? hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrastructure investment. MariMed believes hemp-derived THC beverages provide a scalable pathway to incremental revenue and accretive gross margin, while maintaining disciplined capital deployment. Distributing a hemp-derived version of Vibations also advances MariMed's Expand the Brand strategy, which is focused on broadening distribution of the Company's core brands and achieving a goal of owning top-selling, national cannabis brands. According to BDSA and Lit Alerts, Vibations is a top 10 selling cannabis beverage brand in Illinois, Massachusetts, Maryland, and Delaware. The hemp-derived THC version of Vibations is infused with 5mg of THC per stick. Flavors available for the Rhode Island launch include Lemon Lime (Sugar Free), Half & Half, Strawberry Lemonade, and Tropical Punch. Distribution will be provided through licensed Rhode Island liquor stores that are authorized to carry hemp THC beverages and products, providing an efficient and scalable retail channel for market entry. There are currently more than 150 licensed and approved liquor stores in the state. Distribution of Vibations in Rhode Island is supported by Craft Collective Homegrown, the leading hemp beverage distributor in the state, which will manage weekly ordering and delivery. MariMed has also entered a new partnership with Modern Infusions, the hemp THC beverage division of Theory Wellness, to manage sales execution and local marketing initiatives, including distributor management, account development, retail merchandising, and short and long-term sales planning. The Company is also developing plans to expand distribution of Vibations into additional markets during the first half of 2026. Those plans will be contingent on the early performance of the Rhode Island launch and other regulatory considerations and would be implemented using a similarly disciplined and capital-efficient distribution model.
お知らせ • Oct 29Marimed Announces Strategic Exit from Missouri MarketMariMed Inc. announced that it has completed a strategic review of its Missouri business operations and decided to exit the market, effectively immediately. Since 2024, the Company has managed the Missouri operations of another licensed cannabis operator and distributed certain of its brands there under a Managed Services and Licensing Agreement, while awaiting license transfer approval from the state. The Company will no longer manage the facility and will no longer seek the license transfer. MariMed continues to own or manage revenue-generating operations in six states, including 13 dispensaries and six cultivation and processing facilities in Delaware, Illinois, Maryland, Massachusetts, Ohio, and Pennsylvania. Exiting Missouri is expected to improve the Company’s overall financial performance, particularly gross margin and adjusted EBITDA, and allow management to focus resources on higher return opportunities.
お知らせ • Sep 29MariMed Inc. to Report Q3, 2025 Results on Nov 05, 2025MariMed Inc. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025
お知らせ • Jul 08MariMed Inc. to Report Q2, 2025 Results on Aug 06, 2025MariMed Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
お知らせ • May 29MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDoseMariMed Inc. continued to drive innovation with the launch of MycroDose by Nature's Heritage, a vegan line of all-natural wellness products that combine the power of full-spectrum cannabis with the added benefits of functional mushrooms in a convenient pill form. MycroDose by Natures Heritage delivers four targeted, plant-based solutions designed to enhance mental clarity, promote relaxation, improve focus, and support overall well-being in four distinct formulations. They are available now in Massachusetts at MariMed's own Panacea Wellness stores and other select dispensaries. The new line was developed to provide new and existing consumers with a unique, balanced, and controlled experience. Each of the four MycroDose by Nature' Heritage products are uniquely crafted with a specific blend of all natural vegan ingredients to cater to a variety of needs. The complete line-up includes: Chill - Designed for relaxation and stress relief, Chill features THC, CBD, and q, blended with the functional mushrooms Organic Cordyceps and Organic Lion's Mane, and the root plant, Ashwagandha. G'Night - A formulation aimed at improved sleep and deep relaxation, G'Night combines THC, CBN, CBD with functional mushrooms Organic Reishi and Organic Lion's Mane, as well as Chamomile and Magnesium. Remedy - A product focused on reducing inflammation while providing a calm state of mind, Remedy features THC, CBD, and CBC, blended with the functional mushroom Oyster, Ginger root, Turmeric, and Piperine. Spark - An energizing blend designed to improve energy, focus, and mental clarity, Spark is formulated with Shoitake mushrooms, Organic Lion's Mane, Ginseng, THCV, and THC.
お知らせ • May 01MariMed Inc., Annual General Meeting, Jun 12, 2025MariMed Inc., Annual General Meeting, Jun 12, 2025. Location: sheraton norwood, 1125 boston providence turnpike, norwood, massachusetts 02062, United States
お知らせ • Apr 08MariMed Inc. to Report Q1, 2025 Results on May 07, 2025MariMed Inc. announced that they will report Q1, 2025 results After-Market on May 07, 2025
お知らせ • Apr 07MariMed Inc. Promotes Ryan Crandall to Chief Commercial OfficerMariMed Inc. has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine. Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty’s Eddies. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2.
お知らせ • Apr 03MariMed Inc.'s Betty's Eddies Expands Top-Selling Brand with Introduction of THC & CBG-Infused Caramel ChewsBetty's Eddies is expanding its lineup with the introduction of delicious caramel chews: Betty's Caramelt Away. Betty's Eddies is one of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. Deuting in time for National Caramel Day on April 5, Betty's Caramelt Away chews are now available at select cannabis retailers throughout Massachusetts, with plans for expansion into MariMed's wholesale markets in the future. Each chew wraps customers in warmth with the rich, comforting flavor of classic caramel. They're infused with a soothing blend of full-spectrum hash and CBG that lets consumers sink into sweet, cozy melty moments of mellow. Betty's Caramelt Away joins a full slate of Betty's Eddies products that feature specific end-effects, including Bedtime Betty's for restful nights, Take It Easy Eddies for stress relief, Go Betty Go for an energy boost, Ache Away Eddies for pain relief, Smashin' Passion for sexual wellness, and Betty Good Times for any time.
お知らせ • Apr 02Marimed Launches Nature's Heritage Flower in IllinoisMariMed Inc. has officially introduced its Nature's Heritage™?-branded cannabis flower, pre-rolls, and vapes in Illinois. This marks the first time the brand's premium products are available in the state. The launch follows the late 2024 openning of MariMed's Mt. Vernon, Illinois, cultivation facility. Nature's Heritage products are available at MariMed's five -branded dispensaries and other select retailers in the state. Thrive-branded dispensaries and other select retailer in the state. The entire portfolio of MariMed's award-winning brands is now available in the state. The Company's processing facility commenced distribution of its other products, including Betty's Eddies™?, Bubby's Baked™?, InHouse™?, and Vibations™? products, in late 2023. Since then, MariMed has successfully penetrated the market, with its products currently available in approximately 82% of Illinois dispensaries.
お知らせ • Mar 05MariMed Inc. (OTCPK:MRMD) completed the acquisition of First State Compassion Center Inc.MariMed Inc. (OTCPK:MRMD) entered into an agreement to acquire First State Compassion Center Inc. on July 1, 2023. MariMed Inc. (OTCPK:MRMD) completed the acquisition of First State Compassion Center Inc. on March 3, 2025.
お知らせ • Feb 11MariMed Inc. to Report Q4, 2024 Results on Mar 05, 2025MariMed Inc. announced that they will report Q4, 2024 results After-Market on Mar 05, 2025
お知らせ • Oct 07MariMed Inc. to Report Q3, 2024 Results on Nov 06, 2024MariMed Inc. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024
お知らせ • Aug 08+ 1 more updateMarimed Inc. Reaffirms Earnings Guidance for the Full Year 2024MariMed Inc. reaffirmed earnings guidance for the full year 2024. MariMed's full year 2024 financial targets are based on organic growth of its existing operating assets and do not include new revenue-generating projects requiring regulatory approvals. As such, the Company's full year 2024 financial targets remain at: Revenue growth of 5% to 7%.
お知らせ • Jul 10MariMed Inc. to Report Q2, 2024 Results on Aug 07, 2024MariMed Inc. announced that they will report Q2, 2024 results on Aug 07, 2024
お知らせ • Jul 02MariMed Inc. Announces Approval of Adult-Use Sales at Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and MarylandMariMed Inc. announced that it received approval of the Massachusetts Cannabis Control Commission ("MCCC") to commence adult-use retail sales at its QuincyPanacea Wellness dispensary. Panacea WellnessQuincy is the third MariMed dispensary in Massachusetts that offers adult-use sales, which is the maximum permissible by state law. The other two adult-use dispensaries are in Leverly and Middleboro. The Company commenced adult-use sales in Quincy on July 2, 2024. The dispensary, which has been operating as a medical-only location, offers a curated selection of products from across the Company's award-winning brand portfolio. They include Nature's Heritage flower and concentrates, Betty's Eddies fruit chews, Bubby's Baked soft-baked goods, Vibations hydrating cannabis drink mixes, and the full suite of InHouse branded products. In addition to the three Panacea Wellness locations, MariMed's branded cannabis products are distributed to over 200 dispensaries in the Massachusetts cannabis market, which, according to the MCCC, generated $1.8 billion in total cannabis sales during 2023. The Company also announced regulatory approval updates that may have a positive impact on future operational and financial results. These include: Ohio: Receipt of a provisional dual-use license to add recreational sales to medical dispensary in Tiffin. Upon state final inspection, MariMed expects to commence adult-use sales. Maryland: Receipt of a Certificate of Occupancy and state approval to commence operations in the newly expanded area of cultivation facility in Hagerstown, Maryland. MariMed will begin growing in the new flower rooms immediately to meet the high demand for its Nature's Heritage flower and other branded products in that state. Also in Maryland, the pre-occupancy inspection of second Thrive dispensary in the state is expected to occur. The Company hopes to commence adult-use operations in this dispensary, located in Upper Marlboro, a town in Prince George's County, later this month.
お知らせ • May 10MariMed Inc. Provides Earning Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company's financial targets remain at: revenue growth of 5% to 7%.
お知らせ • Apr 10MariMed Inc. (OTCPK:MRMD) completed the acquisition of Operating assets of Our Community Wellness & Compassionate Care Center, Inc for $5.3 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million on February 1, 2024. The purchase consideration is comprised of $2 million of cash in the aggregate, a $2 million note to be issued to the sellers at the time of closing, and shares of MariMed's common stock with a fair value of $1.25 million based on a formulaic calculation, to be issued at the time of closing. Transaction is subject to approval by the Maryland Cannabis Administration. MariMed expects this acquisition to be completed in 2024. MariMed Inc. (OTCPK:MRMD) completed the acquisition of Operating assets of Our Community Wellness & Compassionate Care Center, Inc on April 9, 2024.
お知らせ • Apr 09MariMed Inc. to Report Q1, 2024 Results on May 08, 2024MariMed Inc. announced that they will report Q1, 2024 results After-Market on May 08, 2024
お知らせ • Mar 20MariMed Inc., Annual General Meeting, Jun 06, 2024MariMed Inc., Annual General Meeting, Jun 06, 2024.
お知らせ • Mar 08MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Operating assets of Our Community Wellness & Compassionate Care Center, Inc. for $5.3 million on February 1, 2024. The purchase consideration is comprised of $2 million of cash in the aggregate, a $2 million note to be issued to the sellers at the time of closing, and shares of MariMed's common stock with a fair value of $1.25 million based on a formulaic calculation, to be issued at the time of closing. Transaction is subject to approval by the Maryland Cannabis Administration. MariMed expects this acquisition to be completed in 2024.
お知らせ • Mar 07MariMed Inc. Provides Earnings Guidance for the Full Year 2024MariMed Inc. provided earning guidance for the full year 2024. For the year, the company expects revenue growth of 5% to 7%.
お知らせ • Feb 06MariMed Inc. to Report Q4, 2023 Results on Mar 06, 2024MariMed Inc. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Mar 06, 2024
お知らせ • Dec 04MariMed Inc. Commences Operations of Processing Facility in Mt. Vernon, IllinoisMariMed Inc. announced it has begun manufacturing and processing cannabis products in its new processing kitchen in Mt. Vernon, Illinois. After lengthy construction and regulatory delays, the Company expects that its award-winning products will be available at dispensaries in Illinois in time for the holidays. These include MariMed's five Thrive Dispensary-branded retail locations in the state. The processing facility contains an extraction lab to produce concentrates, and a production kitchen for the manufacture of edibles and other derivative products. The cultivation facility is currently under construction in the same facility and is expected to be completed in 2024. MariMed intends to manufacture and distribute its proprietary brands and products throughout Illinois. That includes its Betty's Eddies fruit chews, which was the top-selling edible in Illinois until 2020 through a third-party licensing agreement, Bubby's Baked soft and chewy baked edibles, Vibations hydrating drink mix, InHouse gummies, K Fusion chewable tablets, and more. Upon completion of the cultivation facility construction the Company plans to commence selling its Nature's Heritage flower through retail and wholesale channels. MariMed operates five Thrive Dispensary locations in Anna, Casey, Harrisburg, Metropolis, and Mt. Vernon, Illinois.
お知らせ • Nov 05MariMed Inc. Announces Executive ChangesMariMed Inc. announced that effective October 31, 2023, Susan M. Villare resigned as Chief Financial Officer of the Company. The Board of Directors has appointed Jon Levine, President and CEO, as the Company’s Interim Chief Financial Officer and has initiated a search process to identify and engage a new Chief Financial Officer.
お知らせ • Nov 04MariMed Inc. to Report Q3, 2023 Results on Nov 08, 2023MariMed Inc. announced that they will report Q3, 2023 results After-Market on Nov 08, 2023
お知らせ • Sep 14MariMed Inc. Announces its Bubby's Baked Introduces New THC-Infused Blueberry Muffin Bites to Start Day on High NoteMariMed Inc. headed to the blueberry bush to create the latest addition to its Bubby’s Baked™ THC-infused soft baked goods line of edibles. The Company’s new Blueberry Muffin bites are soft and baked in small batches, a made-from-scratch ode to breakfast. They join the popular Bubby’s Baked line inspired by the original pot brownie recipe and are available at select dispensaries in Massachusetts, Maryland, and Delaware. Each Bubby’s Baked Blueberry Muffin bite is an enticing combination of sweetness and tartness, bursting with real blueberries and infused with full-spectrum cannabis. With 35% of cannabis consumers saying they have recently enjoyed a cannabis baked good, Bubby’s Baked Blueberry Muffin bites are sure to satisfy the most discerning sweet tooth. In Massachusetts, they are precision-dosed with 5 mg of cannabis; in Maryland and Delaware, they are available with 10 mg of cannabis. The new Blueberry Muffin bites join the other three flavors in the Bubby’s Baked line-up, including classic Brownie, Choco Chip and Snickerdoodle. The Bubby’s Baked brand was inspired by the original homemade pot brownie. The brand’s classic Brownie flavor was intended to recreate and elevate the nostalgic experience so many consumers remember as their first cannabis-infused edible. Other flavors in the line include Choco Chip and Snickerdoodle.
お知らせ • Jun 30MariMed Inc. to Report Q2, 2023 Results on Aug 02, 2023MariMed Inc. announced that they will report Q2, 2023 results After-Market on Aug 02, 2023
お知らせ • May 09MariMed Inc. Provides Revenue Guidance for the Full Year 2023MariMed Inc. provided revenue guidance for the full year 2023. For the period, the company expects revenue of at least $150 million.
お知らせ • Feb 02MariMed Inc. to Report Q4, 2022 Results on Mar 01, 2023MariMed Inc. announced that they will report Q4, 2022 results After-Market on Mar 01, 2023
お知らせ • Jul 12MariMed Inc. to Report Q2, 2022 Results on Aug 08, 2022MariMed Inc. announced that they will report Q2, 2022 results After-Market on Aug 08, 2022
お知らせ • May 13+ 1 more updateMariMed Inc. Announces Appointment of Jon Levine as Chief Administration OfficerMariMed Inc. announced the appointment of Jon Levine to the new role of Chief Administration Officer effective May 12, 2022. Mr. Levine co-founded MariMed with Chief Executive Officer Bob Fireman. As the Company's CFO, he drove the financial discipline required to make MariMed an industry leader. The Company's finance and accounting teams, operations, sales nd marketing, and external communications will all now report to Mr. Levine as CAO.
お知らせ • May 12MariMed Inc. Provides Earnings Guidance for the Full Year 2022MariMed Inc. provided earnings guidance for the full year 2022. For the period, the company expects revenue to be between $145 million and $150 million.
お知らせ • May 06MariMed Inc. (OTCPK:MRMD) acquired Green Growth Group, Inc. for $3.4 million.MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc. for $3.4 million on January 18, 2022. The transaction is subject to customary closing conditions and regulatory approvals. The acquisition is conditioned upon the approval by the IDA, among other closing conditions, which is expected to occur by July 2022. The purchase price of $3.4 million shall be comprised of $1.9 million in cash and shares of the Company's common stock valued at $1.5 million. The close of this transaction enables MariMed to add cultivation, manufacturing, and distribution to its existing retail cannabis operations in Illinois. MariMed will bring its full product portfolio of award-winning and top-selling brands, genetics, and products to one of the top cannabis markets in the United States. The Company has commenced development of a state-of-the-art cultivation and processing facility in Mt. Vernon, IL and anticipates commencing operations in the fourth quarter of 2022. MariMed Inc. (OTCPK:MRMD) completed the acquisition of Green Growth Group, Inc. on May 5, 2022.
お知らせ • Apr 13MariMed Inc. to Report Q1, 2022 Results on May 10, 2022MariMed Inc. announced that they will report Q1, 2022 results After-Market on May 10, 2022
お知らせ • Mar 10MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Provisional Dispensary License from Green House Naturals, LLC.MariMed Inc. (OTCPK:MRMD) entered into a definitive agreement to acquire Provisional Dispensary License from Green House Naturals, LLC on March 8, 2022. The assets of Green House Naturals to be acquired by MariMed include a provisional adult use dispensary license subject to approval of the Massachusetts Cannabis Control Commission, a Host Community Agreement to operate a dispensary from the City of Beverly and the assignment of the leasehold approved for the business. MariMed anticipates the Beverly adult use dispensary will be operational during the second half of 2022.
お知らせ • Feb 16MariMed Inc. to Report Q4, 2021 Results on Mar 16, 2022MariMed Inc. announced that they will report Q4, 2021 results After-Market on Mar 16, 2022
お知らせ • Feb 08Marimed Inc. Top-Selling Brands and Products Now Available in DelawareMariMed Inc. announced that its award-winning cannabis brands and products are now available in Delaware. As a result of new regulations in the Delaware Medical Marijuana program, MariMed has expanded its licensing agreement with First State Compassion Center (“FSC”), a leading Delaware vertically integrated cannabis operator, to produce and distribute its branded cannabis edibles. First State Compassion will have exclusive rights to produce and distribute MariMed’s Betty’s Eddies® infused fruit chews, Bubby’s Baked™ soft and chewy, full-spectrum cannabis baked bites, and k FUSION chewable micro-dose mints. MariMed and FSC have a longstanding advisory relationship. FSC currently licenses MariMed’s Nature’s Heritage® premium flower and concentrates brand. With the addition of Delaware, MariMed’s brands will now be available in six states plus Puerto Rico with more to come in the future.
お知らせ • Jan 19MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc.MariMed Inc. (OTCPK:MRMD) agreed to acquire Green Growth Group, Inc. on January 18, 2022. The transaction is subject to customary closing conditions and regulatory approvals.
お知らせ • Jan 06MariMed Inc. (OTCPK:MRMD) entered into a definitive membership interest purchase agreement to acquire Kind Therapeutics USA, LLC from Jennifer DiPietro, Susan Zimmerman and Sophia Leonard-Burns for $20 million.MariMed Inc. (OTCPK:MRMD) entered into a definitive membership interest purchase agreement to acquire Kind Therapeutics USA, LLC from Jennifer DiPietro, Susan Zimmerman and Sophia Leonard-Burns for $20 million on December 31, 2021. As reported, the aggregate purchase price to be paid by MariMed Inc. for Kind Therapeutics USA shall be $20 million, of which $13.5 million shall be payable in cash (subject to adjustment) and $6.5 million shall be payable by the issuance of four-year 6% promissory notes of the MariMed to the members of Kind Therapeutics. Upon execution, MariMed deposited, in escrow, the sum of $5 million as a contract down-payment. In related transactions, MariMed Advisors Inc., a wholly-owned subsidiary of MariMed Inc. entered into membership interest purchase agreements to acquire Jennifer DiPietro’s entire equity ownership interest of 99.7% in Mari Holdings MD LLC and 94.3% Mia Development LLC on December 31, 2021. The closing of the agreements is subject to the fulfilment of closing conditions including but not limited to approval by the Maryland Medical Cannabis Commission.
お知らせ • Dec 08MariMed Inc. Unveils World’s Large Cannabis-Infused Brownie to Celebrate Launch of Its “Bubby’s Baked” BrandMariMed Inc. unveiled the world’s large cannabis-infused brownie in celebration of the launch of its new brand Bubby’s Baked and National Brownie Day on December 8. Inspired by the original cannabis-infused, homemade brownie, every delicious, soft, and chewy Bubby’s bite is made from scratch in small batches, and infused with precision-dosed, full spectrum cannabis. They’re perfect for sharing high times with friends this holiday season. Bubby’s comes in three classic confectionery recipes – brownie, chocolate chip, and snickerdoodle. The line is available throughout Massachusetts, including MariMed’s Panacea dispensary in Middleborough, Massachusetts. It is expected to hit dispensary shelves in Delaware and Maryland early next year. Bubby’s are made with all natural ingredients, starting with the basics: flour, butter, eggs, and sugar. There are no artificial flavors or preservatives in any flavor. Each Bubby’s single-serving bite contains 5mg of THC in Massachusetts in compliance with state regulations. To commemorate the launch of Bubby’s, MariMed’s craft confectioners in Massachusetts baked a larger-than-life version of a Bubby’s soft-baked brownie that is believed to be the world’s large THC-infused brownie ever made. The confection measures 3 feet wide by 3 feet long and 15 inches tall, weighs a whopping 850 pounds, and contains 20,000mg of THC.
お知らせ • Sep 10Marimed, Inc.'s Betty's Eddies® Brand Launches Singles and Brings Back Multi-PacksMariMed Inc. announced the launch of new SKUs of its Betty’s Eddies brand of cannabis infused fruit chews. Answering the call of the brand’s customers, this month the company is rolling out single-serving options and bringing back multi-packs that will feature a variety of flavors. Offering the Betty’s Eddies brand in a single-serve package will provide a low-cost, convenient option to drive trial of the brand among new customers, as well as for impulse purchases at point-of-sale. All of Betty’s Eddies fruit chews will be offered in the single-serve format, including the sleep-enhancing Betty’s Bedtime, immunity-boosting Elderbetty, libido-inducing Smashin’ Passion. Betty’s Eddies customers were also demanding the relaunch of multi-packs, which will contain an assortment of the brand’s original five classic flavors, including Berry Good Things, Orange You Beautiful, O’ My Grapeness, Little Lemon Heaven, and Lime a Good Person. The multi-pack will also afford new users the opportunity to try multiple flavors in order to pick their favorite on their next purchase. Handcrafted with full-spectrum cannabis oil, organic fruits and vegetables, Betty’s Eddies chews are vegan, gluten-free and dairy-free. The brand has been the top-selling cannabis edible in Maryland and Massachusetts, according to LeafLink, and is also available in Maine, Nevada, Rhode Island, and Puerto Rico.
お知らせ • May 21MariMed Inc. Affirms Revenue Guidance for 2021MariMed Inc. continues to track previously announced 2021 revenue guidance of $100 million.
お知らせ • Mar 25MariMed Inc. Provides Earnings Guidance for the Full Year 2021Marimed Inc. Provides Earnings Guidance for the Full Year 2021. The company is initiating full year 2021 revenue guidance of $100 million.
お知らせ • Mar 19MariMed Inc. to Report Q4, 2020 Results on Mar 24, 2021MariMed Inc. announced that they will report Q4, 2020 results on Mar 24, 2021
お知らせ • Jan 29MariMed Inc. Launches Cannabis-Infused Betty’s Eddies™ “Smashin’ Passion” Aphrodisiac ChewsMariMed Inc. announced that it is heating up the cannabis edibles market in time for Valentine’s Day with the release of its Betty’s Eddies™ Smashin’ Passion chews. Scientifically formulated to stimulate mind and body, Smashin’ Passion chews will be available starting in February at the Company’s spacious Panacea Wellness dispensary in Middleboro, MA, and later at select dispensaries in Massachusetts, Nevada, Rhode Island, and Puerto Rico. The tenth addition to the award-winning Betty’s Eddies line of all-natural fruit chews, Smashin’ Passion chews are made with pure freeze-dried passionfruit and a proprietary blend of four all-natural aphrodisiacs: damiana, horny goat weed, maca root, and muira puama.
お知らせ • Dec 04MariMed Inc. Announces Launch of Nature’s Heritage™ Solventless Concentrates in MassachusettsMariMed Inc. announced the launch of two solventless concentrate products from its wholly owned Nature’s Heritage cannabis brand. One-gram jars of kief and bubble hash extracted from a variety of Nature’s Heritage strains are now available for purchase at dispensaries across Massachusetts, including the Company’s Panacea Wellness dispensary in Middleboro, MA. Kief is the trichome pollen sifted from dry cannabis flower without the use of chemical solvents. It contains the highest concentration of cannabinoids and terpenes on a cannabis plant, and is often referred to as “cannabis crystals” in reference to its appearance and impressive effects. Similarly, bubble hash is an all-natural solventless cannabis extract created through an ice water extraction process. Nature’s Heritage is one of the top-selling cannabis flower brands in Massachusetts and Maryland. With the addition of the kief and bubble hash, the Company continues to grow and expand its portfolio of product offerings under the Nature’s Heritage brand.
お知らせ • Nov 18Marimed Inc. Introduces Nature’S Heritage™ Rso CapsulesMariMed Inc. announced the product release of “RSO” capsules from the company’s proprietary cannabis flower and concentrate brand, Nature’s Heritage. The capsules are made with powderized RSO and are available in 5 mg, 25 mg, and 100 mg doses at the company’s panacea wellness dispensary and other dispensaries in Massachusetts. RSO is a high-THC cannabis oil reported to have positive results for patients managing a variety of medical conditions and their side effects. The RSO name is homage to the Canadian cannabis activist, Rick Simpson, who created the oil to treat his skin cancer after reading a 1975 journal of the National Cancer Institute study about the efficacy of high doses of THC in cancer treatment. RSO has a thick consistency and is traditionally incorporated into foods or beverages for ingestion or used as a topical directly on affected areas.
お知らせ • Nov 05MariMed Inc. to Report Q3, 2020 Results on Nov 09, 2020MariMed Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 09, 2020
お知らせ • Oct 30MariMed Launches ElderBetty ChewsMariMed Inc. announced the release of the new Betty’s Eddies™ ElderBetty chews. This is the first THC-infused cannabis edible on the market in multiple states to include elderberry, vitamin D, and zinc. Betty’s Eddies chews are available for sale in various dosages at more than 150 licensed medical and adult-use cannabis dispensaries in Massachusetts, Maryland, Nevada, Rhode Island, and Puerto Rico.
お知らせ • Oct 06MariMed Launches Natures’ Heritage Solventless “Live Rosin” in MassachusettsMariMed Inc. launched a new line of solventless concentrates under its Nature’s Heritage brand. Live rosin is a highly concentrated solvent-free cannabis hash oil where terpenes and cannabinoids are largely preserved from the natural plant. These Nature’s Heritage concentrates will be available in rotating varieties of sativa, indica, and hybrid strains. Nature’s Heritage has already established itself as one of the top-selling and most sought-after flower brands in Massachusetts and Maryland. The Company is now building on this success with the launch of live rosin and additional products, including other concentrates, a variety of RSO products, vaporizers, and pre-rolls, coming to market over the next several months, all within the Nature’s Heritage brand.
